DECEMBER 2015 / BPI GRANT

NeoNeuro has received a new grant from BPIfrance Financement, CMI- Amorcage 2 to continue our research towards the development of aptamers as diagnostic and therapeutic tools for Alzheimer’s disease.

SEPTEMBER 2105 / BPI GRANT

NeoNeuro has been granted support from BPIfrance Financement under the PIA-1 program for the use of aptamers as a diagnostic and therapeutic tools in Alzheimer’s disease.